Leandro L. Santos

Janus kinase 1 inhibitor <scp>INCB054707</scp> for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase <scp>II</scp> studies*

Afsáneh Alavi, Iltefat Hamzavi, Kurt Brown et al. · British Journal of Dermatology · 2022 · 88 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study

Joslyn S. Kirby, Martin M. Okun, Afsáneh Alavi et al. · Journal of the American Academy of Dermatology · 2023 · 66 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Multielement Analysis of Soft Drinks by X-ray Fluorescence Spectrometry

Orghêda Luíza Araújo Domingues Zucchi, Silvana Moreira, Marcos José Salvador et al. · Journal of Agricultural and Food Chemistry · 2005 · 39 citations

Agriculture, Food Science, Analytical Chemistry +16

In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations

Leandro L. Santos, Nathaniel J. Swofford, Brandon G. Santiago · Current Protocols in Pharmacology · 2020 · 38 citations

Pharmacy, Dermatology, Pharmaceutics +17

A Potent and Selective Kallikrein-5 Inhibitor Delivers High Pharmacological Activity in Skin from Patients with Netherton Syndrome

John Liddle, Véronique Bénéton, Matthew A. Benson et al. · Journal of Investigative Dermatology · 2021 · 32 citations

Medicine, Dermatology, Pharmacology +2